A team of Japanese researchers is developing a medication that enables tooth regrowth. The innovative drug will target individuals lacking a complete set of adult teeth due to congenital factors such as anodontia. Clinical trials are set to begin in 2024, with the aim of making the drug available by 2030. The breakthrough could impact dental treatments such as dentures or implants.
![](https://healsecurity.com/wp-content/uploads/2024/09/cdc-issues-warning-over-recalled-eggs-sold-in-three-states.jpg)
CDC issues warning over recalled eggs sold in three states
The Centers for Disease Control and Prevention (CDC) has issued a warning against recalled eggs linked to 24 hospitalizations due to salmonella infection. The eggs,